FDA Inspection 1163357 — Tianjin Central Pharmaceutical Co., Ltd.
The FDA completed an inspection of Tianjin Central Pharmaceutical Co., Ltd. on Dec 17, 2021 in Tianjin. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Food/Cosmetics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Dec 17, 2021
- Fiscal Year
- 2022
- Product Type
- Food/Cosmetics
- Project Area
- Food Composition, Standards, Labeling and Econ
- Location
- Tianjin (China)